CLL Connections: "Dinner" with the Docs - Central NJ gives you an opportunity to have an in-depth conversation with New Jersey CLL experts and other people who live near you and who are affected by this diagnosis. Please join us on Monday, July 13th 6PM ET for a special evening to discuss CLL treatments and research updates with host Carol Preston who speaks with experts Dr. Andrew Evens and Dr. Kathleen Toomey.
If you are in Central NJ, Register now to join the 90-minute interactive discussion and we will send you a Grubhub gift card so you can enjoy dinner from your local favorite restaurant while you participate, gain confidence, and be inspired from the safety and comfort of your home. Send your CLL related questions in advance to firstname.lastname@example.org.
Are you interested in sharing your personal journey with CLL? If so, please email us at email@example.com.
Registration will be limited to the the first 50 registrants for each event. Please note this event is restricted to households located in Central New Jersey.
This program is sponsored by Janssen Oncology and Pharmacyclics LLC. These organizations has no editorial control. It is produced by Patient Power. Patient Power is solely responsible for program content.
This dinner event is now full. Please give us your name and complete New Jersey mailing address. Send to CLL@patientpower.info. We will send you follow-up information on the content from the educational event.
Hosts and Guests
Online Host, CLL Patient and Advocate
Kathleen Toomey MD
Medical Director, Steeplechase Cancer Center, Robert Wood Johnson University Hospital Somerset
Andrew Evens DO, MSc, FACP
Associate Director for Clinical Services and Director of Lymphoma, Rutgers Cancer Institute of New Jersey and Medical Director, Oncology Service Line, RWJBarnabas Health
Tuesday, November 3, 2020
Catch up on how an old standby continues to evolve. HER2 has been a major part of the breast cancer vocabulary since the 1980s. Nowadays everyone knows their status as a matter of course. But what exactly does that mean?
Episode 9 of 14 in Facing MPN
Wednesday, November 4, 2020
While most myeloproliferative neoplasm (MPN) patients are older adults, children and young adults can be affected as well, and research & treatment for pediatric MPNs is a growing field.
Episode 2 of 3 in Your Prostate Cancer Questions Answered
Wednesday, November 11, 2020
In this edition of our prostate cancer Answers Now series, we’ll learn about the latest in testing and imaging for prostate cancer with hosts & AnCan Prostate Cancer Moderators, Len Sierra and Peter Kafka.